Valbiotis SA (FR:ALVAL) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Valbiotis, a French company focusing on the development of dietary supplements to combat metabolic disorders and cardiovascular diseases, has reported their total number of voting rights and shares as of June 30, 2024. The company, known for its innovative, plant-based approach, markets its products in France and seeks international licensing agreements. Valbiotis is part of the BPI Excellence network and has received European Union funding for research.
For further insights into FR:ALVAL stock, check out TipRanks’ Stock Analysis page.